
Akebia Therapeutics Inc (AKBA) recent activity suggests a positive outlook with the last week’s performance of -7.16%
On Monday, Akebia Therapeutics Inc (NASDAQ: AKBA) was -4.31% drop from the session before settling in for the closing price of $3.25. A 52-week range